Combination cisplatin and carboplatin in advanced squamous cell carcinoma of the head and neck

Cancer Investigation

Volumn 14, Issue 2, 1996, Pages 98-102

  Patton, Jeffrey F ^a   Powell, Bayard L ^a   White, Douglas R ^a   Russell, Gregory B ^a   Inabinet, Robin T ^a   Muss, Hyman B ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; GRANULOCYTOPENIA; HEAD AND NECK CANCER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 0029983665     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909609018883     Document Type: Article

References (25)

1. Kish JA, Weaver A, Jacobs J, Cummings G, Al-Sarraj M: Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck. Cancer 53:1819-1824, 1984.
2. Rowland KM, Taylor SG, O'Donnell MR, Spiers AS, DeConti RC, Showel J: Cisplatin and 5-FU infusion chemotherapy in advanced recurrent cancer of the head and neck: An Eastern Cooperative Oncology Group pilot study. Cancer Treat Rep 70:461-464, 1986.
3. Creagen E, Ingle J, O'Fallon JR: A phase II study of cisdiaminedichloroplatinum and 5-fluorouracil in advanced upper aerodigestive neoplasms. Head Neck Surg 6:1020-1023, 1984.
4. Choksi AJ, Hong WK, Dimery IW, James P, Guillamondequi DM, Byers RM: Continuous cisplatin (24-hour) and 5-fluorouracil (120-hour) infusion in recurrenthead and neck squamous cell carcinoma. Cancer 61:909-912, 1988.
5. Wittes R, Heller K, Randolph V, Howard J, Vallejo A, Farr H: Cis-dichlorodiammineplatinum (II)-based chemotherapy as initial treatment of advanced head and neck cancer. Cancer Treat Rep 63:1533-1538, 1979.
6. Panettiere FJ, Lehane D, Fletcher WS, Stephens R, Rivkins SR, McCracken JD: Cisplatin therapy of previously treated head and neck cancer: The Southwest Oncology Group's two-dose-per-month outpatient regimen. Med Pediatr Oncol 8:221-225, 1980.
7. Jacobs C, Bertino JR, Goffmet DR, Fee WE, Goode RL: 24-Hour infusion of cis-platinum in head and neck cancers. Cancer 42:2135-2140, 1978.
8. Jacobs C, Meyers F, Hendrickson C, Kohler M, Carter S: A randomized phase III study of cisplatin with or without methotrexate for recurrent squamous cell carcinoma of the head and neck. A Northern California Oncology Group study. Cancer 52:1563-1569, 1983.
9. Hong WK, Schaefer S, Issel B, Cumings C, Luedke D, Bromer R: A prospective randomized trial of methotrexate versus cisplatin in the treatment of recurrent squamous cell carcinoma of the head and neck. Cancer 52:206-210, 1983.
10. Sako K, Razack MS, Kalnins I: Chemotherapy for advanced and recurrent squamous cell carcinoma of the head and neck with high and low dose cis-diamminedichloroplatinum. Am J Surg 136:529-533, 1978.
11. Loehrer PJ, Einhorn LH: Cisplatin. Ann Intern Med 100:704-713, 1984.
12. Eisenberger M, Hornedo J, Silva H, Donehower R, Spaulding M, Van Echo D: Carboplatin (NSC-241-240): An active platinum analog for the treatment of squamous-cell carcinoma of the head and neck. J Clin Oncol 4:1506-1509, 1986.
13. De Andres BL, Lopez PA, Alba E, Sampedro F: Carboplatin, an active drug in advanced head and neck cancer. Cancer Treat Rep 70:1173-1176, 1986.
14. Al-Sarraj M, Metch B, Kish J, Ensley J, Rinehart JJ, Schuller DE: Platinum analogs in recurrent and advanced head and neck cancer: A Southwest Oncology Group and Wayne State University Study. Cancer Treat Rep 71:723-726, 1987.
15. Evans BD, Raju KS, Calvert AH, Harland SJ, Willshaw E: (cis-diammine-1,1 -cyclobutane dicarboxylate platinum II): A new platinum analogue active in the treatment of advanced ovarian carcinoma. Cancer Treat Rep 67:997-1000, 1983.
16. Wiltshaw E: Ovarian trials at the Royal Marsden. Cancer Treat Rev 12(Suppl A):67-71, 1985 (abstract).
17. Hong R, Ohnuma T, Inoue S, Sun AS, Holland JF: Cisplatin and Carboplatin in combination. Proc Am Assoc Cancer Res 26:260, 1985 (abstract).
18. Miller A, Hoogstraten B, Staquet M, Winkler A: Reporting results of cancer treatment. Cancer 47:207-214, 1981.
19. Dimery IW, Brooks BJ, Winn R, Martin T, Shirinian M, Hong WK: Phase II trial of carbopiatin plus cisplatin in recurrent and advanced squamous cell carcinoma of the head and neck. J Clin Oncol 9:1939-1944, 1991.
20. Ozols RF, Corden BJ: High-dose cisplatin in hypertonic saline. Ann Intern Med 100:19-24, 1984.
21. Bruckner HW, Wallach R, Cohen CJ, Deppe G, Kabakow B, Ratner L: High dose platinum for the treatment of refractory ovarian cancer. Gynecol Oncol 12:64-67, 1981.
22. Hayes DM, Cvitkovic E, Golbey RB, Scheiner E, Helson L, Krakoff IH: High dose cisplatinum diamminedichloride: Amelioriation of renal toxicity by maomtol diuresis. Cancer 39:1372-1381, 1977.
23. Trump DL, Grem JL, Tutsch KD, Willson JKV, Simon KJ, Alberti D, Storer B, Tormey DC: Platinum analogue combination chemotherapy: Cisplatin and carbopiatin - A phase I trial with pharmacokinetic assessment of the effect of cisplatin administration on carbopiatin excretion. J Clin Oncol 5:1281-1289, 1987.
24. Nitani H, Kobayashi K: Cisplatin/carboplatin therapy in non-small cell lung cancer. Oncology 49(Suppl 1):51-56, 1992.
25. Bertelsen K, Bastholt L: High-dose platinum chemotherapy in advanced ovarian cancer: A phase II study. Gynecol Oncol 44:79-82, 1992.